EMERGENT BIOSOLUTIONS INC (EBS)
US29089Q1058 - Common Stock
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -608.00M | -223.80M | 230.90M | 305.10M | 54.50M | |||
| Depreciation Amortization | 135.40M | 143.30M | 123.80M | 114.50M | 110.70M | |||
| Income Taxes - Deferred | -31.80M | -19.00M | 46.90M | -2.40M | -1.10M | |||
| Change In Working Capital | -82.50M | 500.00K | -156.40M | 8.80M | -42.40M | |||
| Interest Paid | 57.00M | 33.00M | 30.40M | 21.00M | 34.50M | |||
| Taxes Paid | 13.10M | 6.20M | 71.60M | 109.30M | 30.80M | |||
| Other non cash items | 307.30M | 64.90M | 75.90M | 110.00M | 66.30M | |||
| OPERATING CASH FLOW | -279.60M | -34.10M | 321.10M | 536.00M | 188.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -322.80M | -359.50M | -225.00M | -151.00M | -96.90M | |||
| Other Investing Activity | N/A | -21.80M | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | -74.40M | -381.30M | -225.00M | -151.00M | -96.90M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 76.50M | 564.20M | -35.90M | 62.90M | 13.70M | |||
| Stock Issued/Repurchased | 8.00M | -82.10M | -106.00M | 31.60M | 8.20M | |||
| Other Financing Activity | 500.00K | -900.00K | 900.00K | -25.00M | -57.80M | |||
| FINANCING CASH FLOW | 85.00M | 481.20M | -141.00M | 69.50M | -35.90M | |||
| Exchange Rate Effect | -700.00K | 500.00K | -300.00K | -1.00M | 400.00K | |||
| CHANGE IN CASH | -269.70M | 66.30M | -45.20M | 453.50M | 55.60M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -279.60M | -34.10M | 321.10M | 536.00M | 188.00M | |||
| Capital Expenditure | -322.80M | -359.50M | -225.00M | -151.00M | -96.90M | |||
| FREE CASH FLOW | -602.40M | -393.60M | 96.10M | 385.00M | 91.10M | |||
All data in USD